Envestnet Asset Management Inc. Has $151.27 Million Holdings in CME Group Inc. (NASDAQ:CME)

Envestnet Asset Management Inc. grew its position in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 3.3% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 570,206 shares of the financial services provider's stock after buying an additional 18,098 shares during the period. Envestnet Asset Management Inc. owned about 0.16% of CME Group worth $151,270,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. Wayfinding Financial LLC bought a new position in CME Group during the 1st quarter worth approximately $25,000. New Age Alpha Advisors LLC lifted its holdings in shares of CME Group by 50.0% in the 4th quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock worth $30,000 after purchasing an additional 43 shares during the last quarter. Golden State Wealth Management LLC lifted its holdings in shares of CME Group by 612.5% in the 1st quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider's stock worth $30,000 after purchasing an additional 98 shares during the last quarter. Alpine Bank Wealth Management acquired a new position in CME Group during the 1st quarter valued at approximately $32,000. Finally, Knuff & Co LLC acquired a new position in CME Group during the 4th quarter valued at approximately $33,000. Institutional investors own 87.75% of the company's stock.

Insider Activity

In other news, Director William R. Shepard bought 256 shares of the stock in a transaction on Wednesday, June 25th. The shares were purchased at an average price of $270.53 per share, for a total transaction of $69,255.68. Following the completion of the purchase, the director directly owned 258,196 shares of the company's stock, valued at $69,849,763.88. This trade represents a 0.10% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Phyllis M. Lockett sold 1,060 shares of the business's stock in a transaction dated Monday, May 19th. The shares were sold at an average price of $277.88, for a total value of $294,552.80. Following the completion of the transaction, the director owned 3,108 shares in the company, valued at $863,651.04. This trade represents a 25.43% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 13,400 shares of company stock worth $3,680,610. Corporate insiders own 0.30% of the company's stock.

Analyst Ratings Changes

CME has been the subject of a number of analyst reports. JPMorgan Chase & Co. reduced their price objective on CME Group from $223.00 to $211.00 and set an "underweight" rating for the company in a research report on Thursday, April 24th. Citigroup boosted their price objective on CME Group from $265.00 to $275.00 and gave the company a "neutral" rating in a research report on Thursday, July 3rd. UBS Group lifted their target price on CME Group from $290.00 to $305.00 and gave the company a "buy" rating in a research note on Friday, April 25th. Oppenheimer lifted their target price on CME Group from $282.00 to $300.00 and gave the company an "outperform" rating in a research note on Wednesday, June 4th. Finally, Morgan Stanley lifted their target price on CME Group from $301.00 to $304.00 and gave the company an "overweight" rating in a research note on Thursday, April 24th. Three investment analysts have rated the stock with a sell rating, nine have given a hold rating and five have given a buy rating to the company. According to MarketBeat.com, CME Group presently has a consensus rating of "Hold" and an average price target of $260.93.

CME Group Trading Down 0.0%

NASDAQ CME traded down $0.11 on Friday, hitting $275.08. 1,531,570 shares of the stock were exchanged, compared to its average volume of 2,184,968. The company's 50-day moving average price is $276.58 and its two-hundred day moving average price is $259.23. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a 52-week low of $193.25 and a 52-week high of $290.79. The company has a market capitalization of $99.13 billion, a price-to-earnings ratio of 27.67, a P/E/G ratio of 4.44 and a beta of 0.44.

CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share for the quarter, beating analysts' consensus estimates of $2.61 by $0.19. CME Group had a return on equity of 14.03% and a net margin of 57.71%. The business had revenue of $1.64 billion for the quarter, compared to the consensus estimate of $1.56 billion. During the same quarter in the previous year, the company posted $2.50 earnings per share. CME Group's revenue for the quarter was up 10.4% compared to the same quarter last year. Research analysts predict that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th were given a dividend of $1.25 per share. The ex-dividend date of this dividend was Monday, June 9th. This represents a $5.00 dividend on an annualized basis and a yield of 1.82%. CME Group's payout ratio is presently 50.30%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.